These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37208665)

  • 21. Neuropsychiatric manifestations associated with Juvenile Systemic Lupus Erythematosus: An overview focusing on early diagnosis.
    Nikolaidou A; Beis I; Dragoumi P; Zafeiriou D
    Brain Dev; 2024 Mar; 46(3):125-134. PubMed ID: 38061949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-aquaporin-4 autoantibodies in systemic lupus erythematosus persist for years and induce astrocytic cytotoxicity but not CNS disease.
    Alexopoulos H; Kampylafka EI; Fouka P; Tatouli I; Akrivou S; Politis PK; Moutsopoulos HM; Tzioufas AG; Dalakas MC
    J Neuroimmunol; 2015 Dec; 289():8-11. PubMed ID: 26616866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of antibody binding to aquaporin-4 isoforms in neuromyelitis optica.
    Mader S; Lutterotti A; Di Pauli F; Kuenz B; Schanda K; Aboul-Enein F; Khalil M; Storch MK; Jarius S; Kristoferitsch W; Berger T; Reindl M
    PLoS One; 2010 May; 5(5):e10455. PubMed ID: 20463974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differential diagnosis of neuromyelitis optica spectrum disorders].
    Tanaka K; Tanaka M
    Brain Nerve; 2010 Sep; 62(9):953-60. PubMed ID: 20844306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study.
    Gamal SM; Fouad N; Yosry N; Badr W; Sobhy N
    Arch Rheumatol; 2022 Jun; 37(2):280-287. PubMed ID: 36017206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
    Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
    Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Juvenile- and adult-onset systemic lupus erythematosus: a comparative study in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER).
    Torrente-Segarra V; Salman Monte TC; Rúa-Figueroa I; Sánchez-Alonso F; López-Longo FJ; Galindo-Izquierdo M; Calvo-Alén J; Olivé-Marqués A; Ibañez-Ruán J; Horcada L; Sánchez-Atrio A; Montilla C; Melero González RB; Díez-Álvarez E; Martinez-Taboada V; Andreu JL; Fernández-Berrizbeitia O; Hernández-Beriain JÁ; Gantes M; Hernández-Cruz B; Pecondón-Español Á; Marras C; Bonilla G; Pego-Reigosa JM;
    Clin Exp Rheumatol; 2017; 35(6):1047-1055. PubMed ID: 28628467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
    Kovacs KT; Kalluri SR; Boza-Serrano A; Deierborg T; Csepany T; Simo M; Rokusz L; Miseta A; Alcaraz N; Czirjak L; Berki T; Molnar T; Hemmer B; Illes Z
    Mult Scler; 2016 Aug; 22(9):1192-201. PubMed ID: 26514978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum sFas, sTRAIL, and reduced sFasL in juvenile-onset systemic lupus erythematosus.
    Liphaus BL; Kiss MHB; Carrasco S; Palmeira P; Goldenstein-Schainberg C; Carneiro-Sampaio M
    Clin Rheumatol; 2017 Dec; 36(12):2847-2852. PubMed ID: 28378099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychiatric lupus in Malaysian children: clinical characteristics, imaging features and 12-month outcomes.
    Lim SC; Md-Yusof YL; Johari B; Abdul-Kadir RF; Tang SP
    Turk J Pediatr; 2021; 63(5):743-751. PubMed ID: 34738356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aquaporin-4-autoimmunity in patients with systemic lupus erythematosus: A predominantly population-based study.
    Asgari N; Jarius S; Laustrup H; Skejoe HP; Lillevang ST; Weinshenker BG; Voss A
    Mult Scler; 2018 Mar; 24(3):331-339. PubMed ID: 28326889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence, diagnostic clinical manifestations and severity of juvenile systemic lupus erythematosus in New Zealand Maori and Pacific Island children: the Starship experience (2000-2010).
    Concannon A; Rudge S; Yan J; Reed P
    Lupus; 2013 Oct; 22(11):1156-61. PubMed ID: 24003079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies.
    Kitley J; Leite MI; Küker W; Quaghebeur G; George J; Waters P; Woodhall M; Vincent A; Palace J
    JAMA Neurol; 2013 Nov; 70(11):1375-81. PubMed ID: 23999580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
    Akaishi T; Takahashi T; Fujihara K; Misu T; Fujimori J; Takai Y; Nishiyama S; Abe M; Ishii T; Aoki M; Nakashima I
    J Neurol; 2021 May; 268(5):1938-1944. PubMed ID: 33416998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of autoimmune disorders and autoantibodies in patients with neuromyelitis optica.
    Pereira WLCJ; Reiche EMV; Kallaur AP; Oliveira SR; Simão ANC; Lozovoy MAB; Schiavão LJV; Rodrigues PRDVP; Alfieri DF; Flauzino T; Kaimen-Maciel DR
    Acta Neuropsychiatr; 2017 Jun; 29(3):170-178. PubMed ID: 27692000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance and clinical associations of antibodies to the chromatin antigenic system in juvenile systemic lupus erythematosus.
    Keusseyan SP; da Silva NP; Hilário MO; Okuda EM; Terreri MT; Andrade LE
    Rev Bras Reumatol; 2012 Oct; 52(5):695-712. PubMed ID: 23090370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical value of complement proteins in differentiating AQP4-IgG-positive from MOG-IgG-positive neuromyelitis optica spectrum disorders.
    Qin C; Chen B; Tao R; Chen M; Ma X; Shang K; Wu LJ; Wang W; Bu BT; Tian DS
    Mult Scler Relat Disord; 2019 Oct; 35():1-4. PubMed ID: 31276911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups.
    Massias JS; Smith EMD; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley DP; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan AV; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2020 Apr; 29(5):474-481. PubMed ID: 32233733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
    Jarius S; Wildemann B
    Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.